STAT spoke with Gil Tran, a former HHS and OMB official, on how indirect cost policy may change.September 26, 2025Check out STAT+Sponsored By Courtesy STAT+ | How the government establishes research grant overhead rates: 'It's not like buying a widget' Billions in federal research funds hinge on changes to overhead, or indirect costs. Gil Tran, OMB and HHS veteran, discusses what's at stake By Jonathan Wosen STAT+ | Days before Trump deadline to lower prices, companies push a flurry of initiatives. Will it be enough? The industry hopes that a flurry of new offerings and investments will help it avoid policies that threaten its interests. By Elaine Chen and Daniel Payne STAT+ | Federal judge vacates rule that would have ramped up Medicare Advantage audits A federal judge vacated a Biden-era rule that would have allowed the government to intensify its audits of private Medicare plans. By Tara Bannow Adobe/STAT STAT+ | Opinion: Despite the drama and hype from influencers, longevity science is making real progress The longevity field has made major progress in the past decade, but anti-aging hype is getting in the way. By Paul Knoepfler Opinion: Making health care more accountable and affordable through crowdsourcing To detect and deter waste, fraud, and abuse, HHS should make deidentified data on publicly funded health programs widely available By Ge Bai and David A. Hyman More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Daily Recap? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2025, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments